Associated Papers
High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.
Mattu S et al.
The American Journal of Pathology, 2018
Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.
Kim G et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2018
β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.
Colombo C et al.
Molecular Oncology, 2017
28627792 (PubMed )
Supplement: MOL2-11-1495-s003.docx
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Kato S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
27683183 (PubMed )
Supplement: 10780432ccr161679-sup-168576_1_supp_3636667_wcc1ns.docx
β-Catenin mutation status and outcomes in sporadic desmoid tumors.
Mullen JT et al.
The Oncologist, 2013
Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y et al.
Oncogene, 2000
Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.
Nhieu JT et al.
The American Journal of Pathology, 1999
Select a paper to view details